首页> 外文学位 >The use of misoprostol for labour and delivery.
【24h】

The use of misoprostol for labour and delivery.

机译:米索前列醇用于分娩和分娩的用途。

获取原文
获取原文并翻译 | 示例

摘要

Chapter 1 gives a general introduction to the thesis and covers the pharmacological, physiological and clinical background for induction of labour and the prevention and treatment of postpartum haemorrhage. Chapter 2 describes a randomised controlled trial of 200 nulliparous patients undergoing induction of labour with 50 mug of intravaginal misoprostol regimen versus intravaginal dinoprostone regimen. The study shows that the misoprostol resulted with a quicker induction to delivery time with no difference in neonatal outcome. However it was noticed that more suboptimal cardiotocographs were recorded and there was more clinician input in this group. Chapter 3 describes an observational randomised trial of 104 multiparous patients as it was thought that the labour dynamics of nulliparous patients and multiparous patients differed and therefore should be investigated separately. A two dose regimen of 50mug intravaginal misoprostol was compared with a single dose regimen on an intention to treat basis. The two dose regimen led to a quicker induction to delivery time, despite there being no difference in misoprostol doses in 70% patients in both study arms. The results were surprising, and this is discussed in the chapter. Chapter 4 describes a randomised controlled trial of 64 patients, located in South Africa in hospitals whose resources were those of a developing country. The study compared first line treatment options for primary postpartum haemorrhage, which was caused by uterine atony. 800mug rectal misoprostol was compared with the local routine treatment of intramuscular Syntometrine and an intravenous infusion of oxytocin. Misoprostol performed so well that the study was terminated early due clear differences between the treatments arms. Chapter 5 describes an observational randomised study of 40 patients, comparing 500mug oral misoprostol with 10 i.u. oxytocin for the third stage at caesarean section. It shows that the misoprostol and oxytocin group did not reveal any difference with respect to blood loss at caesarean section, peri-operative haemoglobin changes and need for further oxytocic agents. Chapter 6 contains an overall discussion of the role of misoprostol in induction of labour and postpartum haemorrhage. Nonetheless chapter 2 to 5 also contain a discussion pertinent to each clinical trial that comprised this MD thesis. This chapter reflects the great controversy and debate surrounding this area and draws conclusions. Future areas of research work are postulated.
机译:第1章对论文进行了概述,涵盖了引产以及产后出血的防治的药理,生理和临床背景。第2章介绍了一项随机对照试验,其中200例未出生患者接受50杯阴道内米索前列醇方案对阴道内使用地诺前列酮方案进行引产。研究表明,米索前列醇诱导分娩时间更快,新生儿结局无差异。然而,值得注意的是,记录了更多的次佳心动描记器,并且该组中有更多的临床医生输入。第3章描述了一项针对104例多产患者的观察性随机试验,因为认为未产多产患者和多产患者的劳动动态不同,因此应单独进行调查。在治疗的基础上,将两剂50 ug阴道内米索前列醇方案与单剂方案进行了比较。尽管两个研究组中70%的患者米索前列醇剂量没有差异,但两种剂量方案导致更快地诱导分娩时间。结果令人惊讶,本章对此进行了讨论。第4章描述了一项随机对照试验,对64例患者进行了随机对照试验,这些患者位于南非医院,这些医院的资源来自发展中国家。该研究比较了由子宫收缩乏力引起的原发性产后出血的一线治疗方案。将800mug直肠米索前列醇与肌肉内Syntommetrine的局部常规治疗和静脉注射催产素进行比较。米索前列醇的效果非常好,由于治疗组之间存在明显差异,因此该研究提早终止。第5章介绍了一项针对40例患者的观察性随机研究,将500杯口服米索前列醇与10例i.u进行了比较。催产素用于剖宫产的第三阶段。结果表明,米索前列醇和催产素组在剖宫产失血,围手术期血红蛋白变化以及是否需要其他催产剂方面没有发现任何差异。第6章全面讨论了米索前列醇在引产和产后出血中的作用。尽管如此,第2至第5章还包含与组成该MD论文的每个临床试验有关的讨论。本章反映了围绕该领域的巨大争议和辩论,并得出了结论。假设未来的研究工作领域。

著录项

  • 作者

    Lokugamage, Amali Upulmini.;

  • 作者单位

    University of London, University College London (United Kingdom).;

  • 授予单位 University of London, University College London (United Kingdom).;
  • 学科 Pharmaceutical sciences.;Obstetrics.
  • 学位 M.D.
  • 年度 2004
  • 页码 246 p.
  • 总页数 246
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号